No connection

Search Results

CIM

BEARISH
$13.57 Live
Chimera Investment Corporation · NYSE
Target $14.83 (+9.3%)
$11.67 52W Range $14.88

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$1.14B
P/E
7.89
ROE
9.0%
Profit margin
62.5%
Debt/Equity
5.08
Dividend yield
13.26%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Chimera Investment Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. While the stock appears undervalued based on a Price/Book of 0.44 and a Graham Number of $34.55, these metrics are likely 'value traps' given the high Debt/Equity ratio of 5.08 and a consistent track record of earnings misses. The technical trend is completely bearish (0/100), and the high dividend yield (13.26%) is precarious given the deteriorating health scores. Overall, the valuation discount is a reflection of systemic risk rather than an opportunity.

Key Strengths

Deep discount to book value (P/B 0.44)
Very low P/E ratio (7.89) relative to sector averages
High current dividend yield of 13.26%
Strong gross margins (92.48%)
Recent Q/Q EPS growth showing a potential short-term bounce

Key Risks

Critical financial health (Piotroski F-Score 2/9)
Excessive leverage with Debt/Equity at 5.08
Chronic failure to meet earnings estimates (1/4 beats in last 4 quarters)
Severe long-term price erosion (5Y Change: -35.9%)
High dividend payout ratio (86.05%) increasing risk of a cut
AI Fair Value Estimate
Based on comprehensive analysis
$12.04
-11.3% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
39
Weak
Value
75
Future
30
Past
25
Health
15
Dividend
50
AI Verdict
High-Risk Value Trap
Key drivers: Piotroski F-Score, Debt/Equity Ratio, Earnings Miss Trend, Technical Trend
Confidence
90%
Value
75/100

Trades at a massive discount to assets, but the market is pricing in significant risk.

Positives
  • P/B 0.44
  • P/E 7.89
  • Graham Number $34.55
Watchpoints
  • Intrinsic value ($12.04) is below current price
Future
30/100

Growth metrics are absent or unreliable; earnings trajectory is downward over 3 years.

Positives
  • Recent Q/Q EPS growth
Watchpoints
  • Consistent earnings misses
  • Bearish technical trend (0/100)
Past
25/100

Historical performance shows a steady decline in earning power.

Positives
  • Short term 1Y recovery (+30.6%)
Watchpoints
  • 5Y Change -35.9%
  • Long-term EPS decline from >$1.00 to ~$0.40
Health
15/100

Severe fundamental deterioration; high leverage is a primary concern.

Positives
  • Current ratio 1.68
Watchpoints
  • Piotroski F-Score 2/9
  • Debt/Equity 5.08
Dividend
50/100

Attractive yield but high risk of instability.

Positives
  • Very high yield (13.26%)
Watchpoints
  • High payout ratio (86.05%)
  • Weak health score threatens sustainability

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$13.57
Analyst Target
$14.83
Upside/Downside
+9.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CIM and closest competitors.

Updated 2026-04-24
CIM
Chimera Investment Corporation
Primary
5Y
-35.9%
3Y
+14.5%
1Y
+30.6%
6M
+10.9%
1M
+9.4%
1W
-0.9%
CSR
Centerspace
Peer
5Y
+15.6%
3Y
+40.2%
1Y
+17.2%
6M
+14.3%
1M
+15.4%
1W
+2.1%
BFS
Saul Centers, Inc.
Peer
5Y
+35.2%
3Y
-8.1%
1Y
-6.4%
6M
-1.2%
1M
+1.6%
1W
-1.1%
ALX
Alexander's, Inc.
Peer
5Y
+28.6%
3Y
+33.4%
1Y
+37.1%
6M
-2.2%
1M
+11.4%
1W
+0.9%
EXP
eXp World Holdings, Inc.
Peer
5Y
-84.6%
3Y
-47.3%
1Y
-31.9%
6M
-44.3%
1M
-5.8%
1W
+1.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
7.89
Forward P/E
6.11
PEG Ratio
3.33
P/B Ratio
0.44
P/S Ratio
3.08
EV/Revenue
37.68
EV/EBITDA
N/A
Market Cap
$1.14B

Profitability

Profit margins and return metrics

Profit Margin 62.49%
Operating Margin 43.18%
Gross Margin 92.48%
ROE 9.04%
ROA 1.59%

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
5.08
High debt
Current Ratio
1.68
Good
Quick Ratio
1.54
Excellent
Cash/Share
$3.64

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Net Margin
42.9%
Total Assets
$15.8B
Liabilities
$13.2B
Equity
$2.6B
Debt/Equity
5.14x
Operating CF
$-0.2B
Free Cash Flow
$-0.2B
FCF Yield
100%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-02-11
$0.53
+5.0% surprise
2025-11-06
$0.37
-20.0% surprise
2025-08-06
$0.41
-10.5% surprise

Real Estate Sector Comparison

Comparing CIM against 128 companies in the Real Estate sector (5 bullish, 22 neutral, 101 bearish)
P/E Ratio
7.89
This Stock
vs
40.95
Sector Avg
-80.7% (Discount)
Return on Equity (ROE)
9.04%
This Stock
vs
-45.04%
Sector Avg
-120.1% (Below Avg)
Profit Margin
62.49%
This Stock
vs
9.23%
Sector Avg
+576.8% (Superior)
Debt to Equity
5.08
This Stock
vs
2.76
Sector Avg
+84.3% (Higher)
Current Ratio
1.68
This Stock
vs
9.53
Sector Avg
-82.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

KARDIS PHILLIP JOHN II
Chief Executive Officer
Stock Award
2026-01-20
194,774 shares
SUNG MIYUN
Officer
Stock Award
2026-01-20
31,164 shares
MACDOWELL JACK LEE JR
Chief Investment Officer
Stock Award
2026-01-20
85,701 shares
VISWANATHAN SUBRAMANIAM
Chief Financial Officer
Stock Award
2026-01-20
54,537 shares
KARDIS PHILLIP JOHN II
Chief Executive Officer
Stock Award
2025-12-18
101,772 shares
VISWANATHAN SUBRAMANIAM
Chief Financial Officer
Stock Award
2025-12-18
47,251 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
3 analysts
UBS
2025-11-18
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning CIM from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile